Kathleen Goin's most recent trade in Palvella Therapeutics Inc. was a trade of 3,026 Common Stock done at an average price of $79.2 . Disclosure was reported to the exchange on Feb. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.16 per share. | 18 Feb 2026 | 3,026 | 1,276 | - | 79.2 | 239,529 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 2,154 | 17,243 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 18 Feb 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 2,148 | 17,184 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 18 Feb 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.96 per share. | 18 Feb 2026 | 1,276 | 0 | - | 80.0 | 102,035 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 48,956 | 48,956 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 97.94 per share. | 21 Jan 2026 | 3,749 | 0 | - | 97.9 | 367,177 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 21 Jan 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 2,154 | 19,397 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 21 Jan 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 2,148 | 19,332 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.49 per share. | 21 Jan 2026 | 553 | 3,749 | - | 95.5 | 52,806 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 96.47 per share. | 17 Dec 2025 | 4,302 | 0 | - | 96.5 | 415,023 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,154 | 21,551 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 17 Dec 2025 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,148 | 21,480 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 17 Dec 2025 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 86.51 per share. | 19 Nov 2025 | 2,802 | 0 | - | 86.5 | 242,388 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 2,154 | 23,705 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 19 Nov 2025 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 2,148 | 23,628 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 19 Nov 2025 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 85.72 per share. | 19 Nov 2025 | 1,500 | 2,802 | - | 85.7 | 128,577 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,559 | 123,559 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 5,373 | 5,373 | - | - | Incentive Stock Option (right to buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 27,843 | 27,843 | - | - | Stock Option (right to buy) |